Hoverink Biotechnologies Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Hoverink Biotechnologies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11088
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hoverink Biotechnologies Inc (Hoverink) formerly Hoverink International Holdings Inc, is a preclinical biopharmaceutical company that discovers, develops, manufactures, and commercializes pharmaceutical preparations and drug treatment for age-related diseases, cancer, gastrointestinal and oncological diseases and disorders. The company’s lead product candidate includes Ladavru, which is developed for treating cirrhosis ascites, cirrhosis, AIDS, and chronic pain, nausea and discomfort associated with chemotherapy. It works in collaboration with pharmaceutical and biotechnology companies to expand its product portfolio. Hoverink is headquartered in Los Angeles, California, the US.

Hoverink Biotechnologies Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Hoverink Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hoverink Biotechnologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hoverink Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hoverink Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hoverink Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Hoverink Biotechnologies Inc, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Hoverink Biotech to Enter into Licensing Agreement to Commercialize Ladavru 10
Equity Offering 11
Hoverink Biotechnologies Withdraws Public Offering of Shares for up to USD131 Million 11
Hoverink Biotechnologies Withdraws Public Offering of Shares for up to USD11.82 Million 12
Debt Offering 13
Hoverink Biotech to Raise USD2.5 Million in Private Placement of Notes 13
Hoverink Biotechnologies Inc – Key Competitors 14
Hoverink Biotechnologies Inc – Key Employees 15
Hoverink Biotechnologies Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Hoverink Biotechnologies Inc, Pharmaceuticals & Healthcare, Key Facts 2
Hoverink Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hoverink Biotechnologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hoverink Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hoverink Biotechnologies Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Hoverink Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Hoverink Biotech to Enter into Licensing Agreement to Commercialize Ladavru 10
Hoverink Biotechnologies Withdraws Public Offering of Shares for up to USD131 Million 11
Hoverink Biotechnologies Withdraws Public Offering of Shares for up to USD11.82 Million 12
Hoverink Biotech to Raise USD2.5 Million in Private Placement of Notes 13
Hoverink Biotechnologies Inc, Key Competitors 14
Hoverink Biotechnologies Inc, Key Employees 15

List of Figures
Hoverink Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Hoverink Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Hoverink Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Hoverink Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Hoverink Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hoverink Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Hoverink Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hoverink Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Hoverink Biotechnologies Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SynCore Biotechnology Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary SynCore Biotechnology Co Ltd (SynCore), a subsidiary of Sinphar Pharmaceutical Co Ltd is a biopharmaceutial company that new drug by research and development management and integration of technology resources. The company’s pipeline products include SB01, SB02, SB03, SB04 and SB05; and diagn …
  • Erin Energy Corp (ERN):企業の財務・戦略的SWOT分析
    Summary Erin Energy Corp (Erin Energy), formerly CAMAC Energy Inc, a subsidiary of CAMAC Energy Holdings Ltd, is an oil and gas company that develops and produces oil and gas assets. The company's portfolio includes seven licenses in four countries and covers an area of approximately 19,000 sq km of …
  • Tesla Energy Operations Inc:企業の戦略的SWOT分析
    Tesla Energy Operations Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Centogene AG:医療機器:M&Aディール及び事業提携情報
    Summary Centogene AG (Centogene) is a biotechnology and genetic diagnostic company which offers genetic testing for rare hereditary disorders. The company provides diagnostic services including whole genome sequencing, whole exome sequencing, clinical exome sequencing, NGS panel genomic, carrier scr …
  • Nuo Therapeutics Inc (AURX):医療機器:M&Aディール及び事業提携情報
    Summary Nuo Therapeutics Inc (Nuo Therapeutics), formerly Cytomedix, is a biomedical company that specializes in biodynamic therapies in the area of wound care. It focuses on commercializing cell-based technologies, which bind the regenerative capacity of the human body to trigger natural healing. T …
  • Rural Bank Limited
    Rural Bank Limited - Strategy, SWOT and Corporate Finance Report Summary Rural Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bharat Heavy Electricals Ltd (BHEL):企業の財務・戦略的SWOT分析
    Bharat Heavy Electricals Ltd (BHEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Laurentian Bank of Canada:企業の戦略・SWOT・財務情報
    Laurentian Bank of Canada - Strategy, SWOT and Corporate Finance Report Summary Laurentian Bank of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Puma Energy Holdings Pte Ltd:企業の戦略的SWOT分析
    Puma Energy Holdings Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • The British United Provident Association Ltd-製薬・医療分野:企業M&A・提携分析
    Summary The British United Provident Association Ltd (Bupa) is a leading global healthcare group. It offers health insurance and other funding products, chronic disease management services, home healthcare services, workplace health services and care services, comprising residential and nursing home …
  • Bionomics Ltd (BNO):企業の財務・戦略的SWOT分析
    Summary Bionomics Ltd (Bionomics) is a biopharmaceutical company that discovers and develops treatments for cancer, and central nervous system disorders such as anxiety, depression and Alzheimer's disease. The company provides pipeline products such as BNC210, BNC 105, BNC101 and BNC375, among other …
  • The Norinchukin Bank
    The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report Summary The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Siam Food Products PCL:企業の戦略・SWOT・財務分析
    Siam Food Products PCL - Strategy, SWOT and Corporate Finance Report Summary Siam Food Products PCL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • RentPath LLC:企業の戦略的SWOT分析
    RentPath LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Fresenius Kabi USA LLC:企業の戦略的SWOT分析
    Fresenius Kabi USA LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Electrovaya Inc (EFL):企業の財務・戦略的SWOT分析
    Electrovaya Inc (EFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Immunicom Inc-医療機器分野:企業M&A・提携分析
    Summary Immunicom Inc (Immunicom) is a specialty biotechnology company with focus on the development of a blood filtering device for the treatment of cancer and autoimmune diseases. The company’s lead program, sTNFR Immunopheresis, is a non-drug based cancer therapy that uses a proprietary immunoads …
  • Woodside Petroleum Ltd (WPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Woodside Petroleum Ltd (Woodside) is an independent oil and gas company that explores, develops, produces and supplies energy. It explores and produces oil and gas from a portfolio of facilities in association with some of the world’s major oil and gas companies. The company operates liquefi …
  • RegeneRx Biopharmaceuticals Inc (RGRX):企業の財務・戦略的SWOT分析
    Summary RegeneRx Biopharmaceuticals Inc (RegeneRx) is a clinical-stage biopharmaceutical company that designs, researches and develops novel peptides targeted at diseases with unmet medical needs. The company offers clinical trials, science and discovery and business development services. Its busine …
  • PNE Wind AG (PNE3)-エネルギー分野:企業M&A・提携分析
    Summary PNE Wind AG (PNE) is a renewable energy company. It has a presence in the entire value added chain in the wind energy sector. The company develops, manages projects, realizes, finances, and operates wind-farm projects. PNE also offers commercial and technical operating management services fo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆